Goserelin acetate implant
This code is not in the latest file (4Q26). It was last listed in 1Q26.
Payment limit per 3.6 MG, by effective quarter, 1Q21 to 1Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.This code is not in the latest file (4Q26). It was last listed in 1Q26.
Payment limit per 3.6 MG, by effective quarter, 1Q21 to 1Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.No NDCs mapped to this code in the 4Q26 crosswalk.
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 1Q26 | $777.502 | +$43.837 | 3.6 MG | Goserelin acetate implant | v1, posted September 15, 2026 |
| 4Q25 | $733.665 | −$0.486 | 3.6 MG | Goserelin acetate implant | v1, posted September 8, 2026 |
| 3Q25 | $734.151 | +$29.01 | 3.6 MG | Goserelin acetate implant | v1, posted March 10, 2026 |
| 2Q25 | $705.141 | +$2.081 | 3.6 MG | Goserelin acetate implant | v1, posted March 10, 2026 |
| 1Q25 | $703.06 | +$28.288 | 3.6 MG | Goserelin acetate implant | v1, posted December 19, 2025 |
| 4Q24 | $674.772 | +$15.238 | 3.6 MG | Goserelin acetate implant | v1, posted June 11, 2025 |
| 3Q24 | $659.534 | +$60.194 | 3.6 MG | Goserelin acetate implant | v1, posted June 11, 2025 |
| 2Q24 | $599.34 | −$9.669 | 3.6 MG | Goserelin acetate implant | v1, posted March 11, 2025 |
| 1Q24 | $609.009 | −$2.337 | 3.6 MG | Goserelin acetate implant | v1, posted December 19, 2024 |
| 4Q23 | $611.346 | −$2.219 | 3.6 MG | Goserelin acetate implant | v1, posted October 10, 2024 |
| 3Q23 | $613.565 | +$51.979 | 3.6 MG | Goserelin acetate implant | v1, posted June 5, 2024 |
| 2Q23 | $561.586 | −$6.343 | 3.6 MG | Goserelin acetate implant | v1, posted February 23, 2024 |
| 1Q23 | $567.929 | −$4.789 | 3.6 MG | Goserelin acetate implant | v1, posted December 6, 2023 |
| 4Q22 | $572.718 | −$3.382 | 3.6 MG | Goserelin acetate implant | v1, posted June 22, 2023 |
| 3Q22 | $576.10 | +$26.457 | 3.6 MG | Goserelin acetate implant | v1, posted June 9, 2023 |
| 2Q22 | $549.643 | +$6.485 | 3.6 MG | Goserelin acetate implant | v1, posted December 14, 2022 |
| 1Q22 | $543.158 | +$17.945 | 3.6 MG | Goserelin acetate implant | v1, posted June 8, 2022 |
| 4Q21 | $525.213 | −$6.413 | 3.6 MG | Goserelin acetate implant | v1, posted June 2, 2022 |
| 3Q21 | $531.626 | −$6.615 | 3.6 MG | Goserelin acetate implant | v1, posted June 2, 2022 |
| 2Q21 | $538.241 | +$36.975 | 3.6 MG | Goserelin acetate implant | v1, posted March 1, 2022 |
| 1Q21 | $501.266 | – | 3.6 MG | Goserelin acetate implant | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.